International Conference on Genetic Biomarkers and Diagnostic Techniques
ICGBDT
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track will explore the latest discoveries in genetic biomarkers and their implications for disease diagnosis and treatment. Emphasis will be placed on innovative approaches to biomarker identification and validation.
SDG 3
SDG 4
This session will focus on cutting-edge molecular diagnostic techniques and their applications in clinical settings. Participants will discuss the integration of these techniques into routine diagnostics and their impact on patient outcomes.
SDG 3
SDG 9
This track will cover the development and application of genomic assays in clinical genomics. Discussions will include the challenges and opportunities presented by these assays in the context of personalized medicine.
SDG 3
SDG 9
This session will address the methodologies and technologies used in biomarker discovery and validation. Emphasis will be placed on the importance of robust validation processes to ensure clinical applicability.
SDG 3
SDG 4
This track will examine the role of predictive and prognostic markers in the management of various diseases. Participants will discuss how these markers can inform treatment decisions and improve patient outcomes.
SDG 3
SDG 9
This session will highlight the use of high-throughput screening technologies in the identification of novel biomarkers. The focus will be on innovative applications and the potential for accelerating biomarker discovery.
SDG 3
SDG 4
This track will explore the emerging field of liquid biopsy and its implications for non-invasive diagnostics. Discussions will include the technical challenges and clinical applications of liquid biopsy in various diseases.
SDG 3
SDG 9
This session will focus on the latest techniques for mutation detection in genomic studies. Participants will discuss the significance of these techniques in understanding disease mechanisms and treatment responses.
SDG 3
SDG 4
This track will examine the development and application of gene panels in clinical practice. Emphasis will be placed on their role in personalized medicine and the challenges associated with their implementation.
SDG 3
SDG 9
This session will focus on the discovery and application of protein biomarkers in disease diagnosis and monitoring. Participants will discuss the technological advancements that facilitate protein biomarker research.
SDG 3
SDG 4
This track will explore the role of therapeutic biomarkers in the development of targeted therapies. Discussions will include the implications of these biomarkers for treatment efficacy and patient stratification.
SDG 3
SDG 9